Metabolomic profiling for dyslipidemia in pediatric patients with sickle cell disease, on behalf of the IHCC consortium.

"Declarations Conflict of InterestThe authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Ethical approvalThis study was approved by the Institutional Review Board (IRB) of the Children’s Hospital of Philadelphia. Human participants and personal information are all encrypted to ensure no PHI are included and study participants are de-identified. All human subjects or their proxies provided written informed consent. Consent for publicationAll authors have provided consent for publication of the manuscript. Conflict of Interest The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

"Funding The study was supported by: The International Hundred Thousand Plus Cohort Consortium (IHCC); CHOP funding: Institutional Development Funds from the Children’s Hospital of Philadelphia to the Center for Applied Genomics, The Children’s Hospital of Philadelphia Endowed Chair in Genomic Research (HH). Grant/award number: Not applicable."